Clinical Neurophysiology, 138, 231-240. ELSEVIER IRELAND LTD Clinical neurophysiology, 138, 231-240. Elsevier Ireland Ltd Dipòsit Digital de la UB Universidad de Barcelona Arends, S, Drenthen, J, van den Bergh, P, Franssen, H, Hadden, R D M, Islam, B, Kuwabara, S, Reisin, R C, Shahrizaila, N, Amino, H, Antonini, G, Attarian, S, Balducci, C, Barroso, F, Bertorini, T, Binda, D, Brannagan, T H, Buermann, J, Casasnovas, C, Cavaletti, G, Chao, C C, Dimachkie, M M, Fulgenzi, E A, Galassi, G, Gutiérrez Gutiérrez, G, Harbo, T, Hartung, H P, Hsieh, S T, Kiers, L, Lehmann, H C, Manganelli, F, Marfia, G A, Mataluni, G, Pardo, J, Péréon, Y, Rajabally, Y A, Santoro, L, Sekiguchi, Y, Stein, B & the IGOS consortium 2022, ' Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study : Differences in methods and reference values ', Clinical Neurophysiology, vol. 138, pp. 231-240 . https://doi.org/10.1016/j.clinph.2021.12.014 Clinical Neurophysiology, 138, 231-240. Elsevier Ireland Ltd Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, Vol. 138, no.1, p. 231-240 (2022)
Neurology, 98(5), E518-E532. Lippincott Williams and Wilkins Neurology, 98(5), E518-E532. LIPPINCOTT WILLIAMS & WILKINS Neurology, 98(5), E518-E532. Lippincott Williams & Wilkins Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome : International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139 Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS Consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139 Neurology
Siddiqi, Z A, Nowak, R J, Mozaffar, T, O'Brien, F, Yountz, M, Patti, F, Mazia, C G, Wilken, M, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D'Hont, A, Tilkin, P, de Siqueira Carvalho, A A, Brockhausen, I D, Feder, D, Ambrosio, D, César, P, Melo, A P, Ribeiro, R M, Rocha, R, Rosa, B B, Andersen, H, Vissing, J, Højgaard, J, Witting, N, Pedersen, J, Weiss, M & The REGAIN Study Group 2021, ' Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab : subgroup analysis of REGAIN and its extension study ', Muscle and Nerve, vol. 64, no. 6, pp. 662-669 . https://doi.org/10.1002/mus.27422 Muscle & nerve, 64(6), 662-669. John Wiley and Sons Inc.
Vissing, J, Jacob, S, Fujita, K P, O’Brien, F, Howard, J F, The REGAIN Study Group, Mazia, C G, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D’Hont, A, Tilkin, P, Alves de Siqueira Carvalho, A, Dias Brockhausen, I, Feder, D, Ambrosio, D, César, P, Melo, A P, Martins Ribeiro, R, Rocha, R, Rosa, B B, Veiga, T, da Silva, L A, Andersen, H, Harbo, T, Vinge, L, Krogh, S, Mogensen, A, Vissing, J, Højgaard, J, Witting, N, Autzen, A M O, Pedersen, J & Weiss, M 2020, ' ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab ', Journal of Neurology, vol. 267, pp. 1991-2001 . https://doi.org/10.1007/s00415-020-09770-y JOURNAL OF NEUROLOGY Journal of Neurology Journal of neurology, 267(7), 1991-2001. D. Steinkopff-Verlag
Annals of Clinical and Translational Neurology Annals of Clinical and Translational Neurology, Vol 7, Iss 8, Pp 1327-1339 (2020) ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY Annals of clinical and translational neurology, 7(8), 1327-1339. John Wiley and Sons Ltd
Andersen, H, Mantegazza, R, Wang, J J, O’Brien, F, Patra, K, Howard, J F & The REGAIN Study Group 2019, ' Eculizumab improves fatigue in refractory generalized myasthenia gravis ', Quality of Life Research, vol. 28, no. 8, pp. 2247-2254 . https://doi.org/10.1007/s11136-019-02148-2 Quality of Life Research QUALITY OF LIFE RESEARCH
REGAIN Study Group 2019, ' Long-term safety and efficacy of eculizumab in generalized myasthenia gravis ', Muscle & Nerve, vol. 60, no. 1, pp. 14-24 . https://doi.org/10.1002/mus.26447 MUSCLE & NERVE Muppidi, S, Utsugisawa, K, Benatar, M, Murai, H, Barohn, R J, Illa, I, Jacob, S, Vissing, J, Burns, T M, Kissel, J T, Nowak, R J, Andersen, H, Casasnovas, C, De Bleecker, J L, Vu, T H, Mantegazza, R, O'Brien, F L, Wang, J J, Fujita, K P, Howard, J F & REGAIN Study Group 2019, ' Long-term safety and efficacy of eculizumab in generalized myasthenia gravis ', Muscle & Nerve, vol. 60, no. 1, pp. 14-24 . https://doi.org/10.1002/mus.26447 Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona Muscle & nerve, 60(1), 14-24. John Wiley and Sons Inc.